Seguir
Michael Gough
Michael Gough
Earle A. Chiles Research Institute, Providence Cancer Center, Portland OR
Dirección de correo verificada de providence.org
Título
Citado por
Citado por
Año
The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis—preliminary findings
RE Banks, MJ Dunn, MA Forbes, A Stanley, D Pappin, T Naven, M Gough, ...
ELECTROPHORESIS: An International Journal 20 (4‐5), 689-700, 1999
4041999
The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis—preliminary findings
RE Banks, MJ Dunn, MA Forbes, A Stanley, D Pappin, T Naven, M Gough, ...
ELECTROPHORESIS: An International Journal 20 (4‐5), 689-700, 1999
4041999
Optimizing timing of immunotherapy improves control of tumors by hypofractionated radiation therapy
KH Young, JR Baird, T Savage, B Cottam, D Friedman, S Bambina, ...
PloS one 11 (6), e0157164, 2016
3002016
Timing of PD-1 blockade is critical to effective combination immunotherapy with anti-OX40
DJ Messenheimer, SM Jensen, ME Afentoulis, KW Wegmann, Z Feng, ...
Clinical Cancer Research 23 (20), 6165-6177, 2017
2872017
PKC-δ is an apoptotic lamin kinase
T Cross, G Griffiths, E Deacon, R Sallis, M Gough, D Watters, JM Lord
Oncogene 19 (19), 2331-2337, 2000
2822000
Radiotherapy combined with novel STING-targeting oligonucleotides results in regression of established tumors
JR Baird, D Friedman, B Cottam, TW Dubensky Jr, DB Kanne, S Bambina, ...
Cancer research 76 (1), 50-61, 2016
2242016
OX40 agonist therapy enhances CD8 infiltration and decreases immune suppression in the tumor
MJ Gough, CE Ruby, WL Redmond, B Dhungel, A Brown, AD Weinberg
Cancer research 68 (13), 5206-5215, 2008
1912008
Facets of heat shock protein 70 show immunotherapeutic potential
SM Todryk, MJ Gough, AG Pockley
Immunology 110 (1), 1-9, 2003
1822003
Signaling through OX40 enhances antitumor immunity
SM Jensen, LD Maston, MJ Gough, CE Ruby, WL Redmond, M Crittenden, ...
Seminars in oncology 37 (5), 524-532, 2010
1722010
Apoptosis or necrosis for tumor immunotherapy: what's in a name?
A Melcher, M Gough, S Todryk, R Vile
Journal of molecular medicine 77, 824-833, 1999
1721999
Adjuvant therapy with agonistic antibodies to CD134 (OX40) increases local control after surgical or radiation therapy of cancer in mice
MJ Gough, MR Crittenden, MC Sarff, P Pang, SK Seung, JT Vetto, HM Hu, ...
Journal of immunotherapy 33 (8), 798-809, 2010
1652010
Viral fusogenic membrane glycoproteins kill solid tumor cells by nonapoptotic mechanisms that promote cross presentation of tumor antigens by dendritic cells
AR Bateman, KJ Harrington, T Kottke, A Ahmed, AA Melcher, MJ Gough, ...
Cancer research 62 (22), 6566-6578, 2002
1532002
Macrophages orchestrate the immune response to tumor cell death
MJ Gough, AA Melcher, A Ahmed, MR Crittenden, DS Riddle, ...
Cancer research 61 (19), 7240-7247, 2001
1472001
Role of the immunosuppressive microenvironment in immunotherapy
GW Tormoen, MR Crittenden, MJ Gough
Advances in radiation oncology 3 (4), 520-526, 2018
1442018
A simple method to cure established tumors by inflammatory killing of normal cells
GA Daniels, L Sanchez-Perez, RM Diaz, T Kottke, J Thompson, M Lai, ...
Nature biotechnology 22 (9), 1125-1132, 2004
1442004
TGFβ suppresses CD8+ T cell expression of CXCR3 and tumor trafficking
AJ Gunderson, T Yamazaki, K McCarty, N Fox, M Phillips, A Alice, T Blair, ...
Nature communications 11 (1), 1749, 2020
1192020
Cells as vehicles for cancer gene therapy: the missing link between targeted vectors and systemic delivery?
K Harrington, L Alvarez-Vallina, M Crittenden, M Gough, H Chong, ...
Human gene therapy 13 (11), 1263-1280, 2002
1192002
Expression of NF-κB p50 in tumor stroma limits the control of tumors by radiation therapy
MR Crittenden, B Cottam, T Savage, C Nguyen, P Newell, MJ Gough
PloS one 7 (6), e39295, 2012
1102012
Defects in the acquisition of CD8 T cell effector function after priming with tumor or soluble antigen can be overcome by the addition of an OX40 agonist
WL Redmond, MJ Gough, B Charbonneau, TL Ratliff, AD Weinberg
The Journal of Immunology 179 (11), 7244-7253, 2007
1052007
A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic …
T Crocenzi, B Cottam, P Newell, RF Wolf, PD Hansen, C Hammill, ...
Journal for immunotherapy of cancer 4, 1-13, 2016
1032016
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20